Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.46 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6743777 | 1.00 | SIGMAR1 (0.50) | SIGMAR1MAPTRXFP1IDO1FFAR1 | |
| SCHEMBL29036387 | 1.00 | SIGMAR1 (0.50) | SIGMAR1MAPTRXFP1IDO1FFAR1 | |
| SCHEMBL11880603 | 1.00 | SIGMAR1 (0.50) | SIGMAR1MAPTRXFP1IDO1FFAR1 | |
| SCHEMBL7107595 | 1.00 | SIGMAR1 (0.50) | SIGMAR1MAPTRXFP1IDO1FFAR1 | |
| SCHEMBL6462217 | 1.00 | SIGMAR1 (0.50) | SIGMAR1MAPTRXFP1IDO1FFAR1 | |
| SCHEMBL7341046 | 0.98 | IDO1 (0.48) | SIGMAR1MAPTRXFP1IDO1FFAR1 | |
| SCHEMBL11277519 | 0.92 | IDO1 (0.55) | SIGMAR1IDO1FFAR1HDAC1MAOA | |
| SCHEMBL11255629 | 0.84 | SIGMAR1 (0.53) | SIGMAR1MAPTRXFP1IDO1MAOA | |
| SCHEMBL11248744 | 0.84 | SIGMAR1 (0.53) | SIGMAR1MAPTRXFP1IDO1MAOA | |
| SCHEMBL2129084 | 0.84 | TDP1 (0.46) | IDO1FFAR1TDP1L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260002024-A1 | FLAME RETARDANT POLYCARBONATE FORMULATIONS | TRINSEO EUROPE GMBH (CH) | 2026-01-01 | — | — | US | disclosed |
| US-20250340735-A1 | POLYCARBONATES WITH HIGH POST-CONSUMER RECYCLE CONTENT | TRINSEO EUROPE GMBH (CH) | 2025-11-06 | — | — | US | disclosed |
| US-20250333572-A1 | RECYCLING METHOD FOR POST-CONSUMER AND/OR POST-INDUSTRIAL IMPACT MODIFIED POLYMERS | TRINSEO EUROPE GMBH (CH) | 2025-10-30 | — | — | US | disclosed |
| EP-4590768-A1 | FLAME RETARDANT POLYCARBONATE FORMULATIONS | Trinseo Europe GmbH (CH) | 2025-07-30 | — | — | EP | disclosed |
| EP-4555008-A1 | RECYCLING METHOD FOR POST-CONSUMER AND/OR POST-INDUSTRIAL IMPACT MODIFIED POLYMERS | Trinseo Europe GmbH (CH) | 2025-05-21 | — | — | EP | disclosed |
| EP-4555016-A1 | POLYCARBONATES WITH HIGH POST-CONSUMER RECYCLE CONTENT | Trinseo Europe GmbH (CH) | 2025-05-21 | — | — | EP | disclosed |
| CN-119654372-A | Method for recycling post-consumer and/or post-industry use impact modified polymers | 盛禧奥欧洲有限责任公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2025036908-A1 | FLAME RETARDANT POLYCARBONATE COMPOSITIONS NOT FORMULATED WITH PFAS ADDITIVE | TRINSEO EUROPE GMBH (CH) | 2025-02-20 | — | — | WO | disclosed |
| EP-4509563-A1 | PFAS COMPOUND FREE FLAME RETARDANT POLYCARBONATE COMPOSITIONS | Trinseo Europe GmbH (CH) | 2025-02-19 | — | — | EP | disclosed |
| EP-4479464-A1 | EXTREMELY LOW ODOR VINYLIDENE SUBSTITUTED AROMATIC POLYMER CONTAINING COMPOSITION | Trinseo Europe GmbH (CH) | 2024-12-25 | — | — | EP | disclosed |
| EP-0926181-A2 | Manufacturing method for polycarbonate | GENERAL ELECTRIC COMPANY (US) | 1999-06-30 | — | — | EP | disclosed |
| US-5760172-A | Process for preparing styrenic resin | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1998-06-02 | — | — | US | disclosed |
| EP-0744410-A2 | Process for preparing styrenic resin | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1996-11-27 | — | — | EP | disclosed |
| EP-0437886-A2 | Stabilizer composition for polymers of vinyl chloride and polymeric compositions containing such compositions | EUROPEAN VINYLS CORPORATION (ITALIA) S.p.A. (IT) | 1991-07-24 | — | — | EP | disclosed |
| EP-0040171-B1 | AZO DYESTUFFS, METHODS FOR THEIR PREPARATION AND THEIR USE AS COLOURING AGENTS IN THE SILVER DYESTUFF BLEACHING PROCESS | CIBA-GEIGY AG (CH) | 1984-03-21 | — | — | EP | disclosed |
| EP-0041474-B1 | N-PHENYLPHOSPHORAMIDATE ESTERS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS COUPLING COMPONENTS | CIBA-GEIGY AG (CH) | 1983-11-16 | — | — | EP | disclosed |
| EP-0041474-A1 | N-phenylphosphoramidate esters, process for their preparation and their use as coupling components | CIBA-GEIGY AG (CH) | 1981-12-09 | — | — | EP | disclosed |
| EP-0040171-A2 | Azo dyestuffs, methods for their preparation and their use as colouring agents in the silver dyestuff bleaching process | CIBA-GEIGY AG (CH) | 1981-11-18 | — | — | EP | disclosed |
| US-4255321-A | BLENDS WITH HIGH IMPACT-STRENGTH BUTADIENE-STYRENE COPOLYMER INCLUDE A SYNERGISTIC MIXTURE OF A METAL SULFIDE AND ZINC OXIDE; ENGINEERING THERMOPLASTICS | GENERAL ELECTRIC COMPANY (US) | 1981-03-10 | — | — | US | disclosed |
| US-4060512-A | ALUMINUM CARBOXYLATE | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260002024-A1 | FLAME RETARDANT POLYCARBONATE FORMULATIONS | PFAS, FGFR3, FGFR2 | SIGMAR1 2521/4885MAPT 1706/4885RXFP1 4749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.